click below
click below
Normal Size Small Size show me how
BDK PHO #1-2
Basic Drug Knowledge Pain, Hematology, and Oncology Page #1-2
| Generic Name | Brand Name | Classification | Pharmacologic Category | Common Indications | Key Side Effects | US Boxed Warnings | US Boxed Warnings Cont. | Additional Info. |
|---|---|---|---|---|---|---|---|---|
| Fentanyl (Transdermal, IV) | Transdermal: Duragesic IV: Sublimaze | CS-II | Opioid Analgesic | Pain | Dizziness, Drowsiness, Nausea, Vomiting, Constipation, Pruritus, Respiratory Depression (Dose-Related) | Risk of opioid addiction, abuse, & misuse which can lead to overdose & death; Serious, life-threatening, or fatal respiratory depression may occur; Accidental ingestion may result in fatal overdose; Prolonged use in pregnancy may result in neonatal opioid | withdrawal syndrome; Abrupt discontinuation may result in serious opioid-induced withdrawal syndrome; concomitant use of opioids with benzodiazepines or CNS depressants (including alcohol) may result in profound sedation, respiratory depression, coma, | US Boxed Warnings Cont.: & death; Potential for medication erros when converting between dosage forms; Use with CYP3A4 inhibitors (or stopping CYP3A4 inducers) can increase fentanyl concentrations; Avoid exposing transdermal patch to external heat |
| Hydromorphone (PO, IV) | Dilaudid | CS-II | Opioid Analgesic | Pain | Dizziness, Drowsiness, Nausea, Vomiting, Constipation, Pruritus, Respiratory Depression (Dose-Related) | Risk of opioid addiction, abuse, & misuse which can lead to overdose & death; Serious, life-threatening, or fatal respiratory depression may occur; Accidental ingestion may result in fatal overdose; Prolonged use in pregnancy may result in neonatal opioid | withdrawal syndrome; Abrupt discontinuation may result in serious opioid-induced withdrawal syndrome; concomitant use of opioids with benzodiazepines or CNS depressants (including alcohol) may result in profound sedation, respiratory depression, coma, | US Boxed Warnings Cont.: & death; Risk of medication errors with high-potency hydromorphone, Use in opioid-tolerant patients only |
| Morphine (Extended Release) (PO) | MS Contin, Kadian | CS-II | Opioid Analgesic | Pain | Dizziness, Drowsiness, Nausea, Vomiting, Constipation, Pruritus, Respiratory Depression (Dose-Related) | Risk of opioid addiction, abuse, & misuse which can lead to overdose & death; Serious, life-threatening, or fatal respiratory depression may occur; Accidental ingestion may result in fatal overdose; Prolonged use in pregnancy may result in neonatal opioid | withdrawal syndrome; Abrupt discontinuation may result in serious opioid-induced withdrawal syndrome; concomitant use of opioids with benzodiazepines or CNS depressants (including alcohol) may result in profound sedation, respiratory depression, coma, | US Boxed Warnings Cont.: & death; Coingestion with alcohol may result in potentially fatal overdose of morphine |
| Morphine (Immediate Release) (PO, IV, IM, PR [Per Rectum]) | IV: Duramorph, Infumorph | CS-II | Opioid Analgesic | Pain | Dizziness, Drowsiness, Nausea, Vomiting, Constipation, Pruritus, Respiratory Depression (Dose-Related) | Risk of opioid addiction, abuse, & misuse which can lead to overdose & death; Serious, life-threatening, or fatal respiratory depression may occur; Accidental ingestion may result in fatal overdose; Prolonged use in pregnancy may result in neonatal opioid | withdrawal syndrome; Abrupt discontinuation may result in serious opioid-induced withdrawal syndrome; concomitant use of opioids with benzodiazepines or CNS depressants (including alcohol) may result in profound sedation, respiratory depression, coma, | |
| Oxycodone (PO) | OxyContin, Roxicodone | CS-II | Opioid Analgesic | Pain | Dizziness, Drowsiness, Nausea, Vomiting, Constipation, Pruritus, Respiratory Depression (Dose-Related) | Risk of opioid addiction, abuse, & misuse which can lead to overdose & death; Serious, life-threatening, or fatal respiratory depression may occur; Accidental ingestion may result in fatal overdose; Prolonged use in pregnancy may result in neonatal opioid | withdrawal syndrome; Abrupt discontinuation may result in serious opioid-induced withdrawal syndrome; concomitant use of opioids with benzodiazepines or CNS depressants (including alcohol) may result in profound sedation, respiratory depression, coma, | US Boxed Warnings Cont.: & death; Use with CYP3A4 inhibitors (or stoppying CYP3A4 inducers) can increase oxycodone concentrations |
| Methadone (PO, IV) | Dolophine | CS-II | Opioid Analgesic | Opioid Use Disorder, Severe Chronic Pain | Dizziness, Drowsiness, Nausea, Vomiting, Constipation, Respiratory Depression (Dose-Related), QTc Prolongation | Risk of opioid addiction, abuse, & misuse which can lead to overdose & death; Serious, life-threatening, or fatal respiratory depression may occur; Accidental ingestion may result in fatal overdose; Prolonged use in pregnancy may result in neonatal opioid | withdrawal syndrome; Abrupt discontinuation may result in serious opioid-induced withdrawal syndrome; concomitant use of opioids with benzodiazepines or CNS depressants (including alcohol) may result in profound sedation, respiratory depression, coma, | US Boxed Warnings Cont.: & death; QTc internal prolongation & serious arrhythmia (Torsades de Pointes) have occurred during treatment; Concomitant use with CYP3A4, 2B6, 2C19, or 2D6 (or stopping the same inducers) can increase methodone concentrations |
| Acetaminophen (PO, PR [Per Rectum], IV) | PO/PR: Tylenol IV: Ofirmev | PO, PR: OTC | Analgesic (Non-Opioid), Antipyretic | Pain, Fever | Nausea, Vomiting, Increased Hepatic Transaminases | Total daily dose from all sources should not exceed maximum daily limit; Hepatotoxicity | ||
| Tramadol (PO) | Ultram, Ultram ER | CS-IV | Central Analgesic; Partial Opioid Agonist | Pain | Dizziness, Drowsiness, Nausea, Vomiting, Constipation, Respiratory Depression (Dose-Related) | Risk of opioid addiction, abuse, & misuse which can lead to overdose & death; Serious, life-threatening, or fatal respiratory depression may occur; Accidental ingestion may result in fatal overdose; Prolonged use in pregnancy may result in neonatal opioid | withdrawal syndrome; Concomitant use of opioids with benzodiazepines or CNS depressants (including alcohol), may result in profound sedation, respiratory depression, coma, & death; Concomitant use or discontinuation of CYP3A4 inducers, 3A4 inhibitors, or | US Boxed Warnings Cont.: 2D6 inhibitors requires careful consideration; respiratory depression & death in children after tonsillectomy or adenoidectomy who are ultra-rapid metabolizers of tramadol Other Notes: Lowers seizure threshold |
| Hydrocodone & Acetaminophen (PO) | Lortab, Vicodin, Norco | CS-II | Opioid and Non-Opioid Analgesic Combination | Pain | Dizziness, Drowsiness, Nausea, Vomiting, Constipation, Pruritus, Respiratory Depression (Dose-Related) | Risk of opioid addiction, abuse, & misuse which can lead to overdose & death; Serious, life-threatening, or fatal respiratory depression may occur; Accidental ingestion may result in fatal overdose; Prolonged use in pregnancy may result in neonatal opioid | withdrawal syndrome; Abrupt discontinuation may result in serious opioid-induced withdrawal syndrome; concomitant use of opioids with benzodiazepines or CNS depressants (including alcohol) may result in profound sedation, respiratory depression, coma, | US Boxed Warnings Cont.: & death; Use with CYP3A4 inhibitors (or stopping CYP3A4 inducers) can increase oxycodone concentrations; Hepatotoxicity |
| Oxycodone & Acetaminophen (PO) | Percocet, Endocet | CS-II | Opioid and Non-Opioid Analgesic Combination | Pain | Dizziness, Drowsiness, Nausea, Vomiting, Constipation, Pruritus, Respiratory Depression (Dose-Related) | Risk of opioid addiction, abuse, & misuse which can lead to overdose & death; Serious, life-threatening, or fatal respiratory depression may occur; Accidental ingestion may result in fatal overdose; Prolonged use in pregnancy may result in neonatal opioid | withdrawal syndrome; Abrupt discontinuation may result in serious opioid-induced withdrawal syndrome; concomitant use of opioids with benzodiazepines or CNS depressants (including alcohol) may result in profound sedation, respiratory depression, coma, | US Boxed Warnings Cont.: & death; Use with CYP3A4 inhibitors (or stopping CYP3A4 inducers) can increase oxycodone concentrations; Hepatotoxicity |
| Codeine & Acetaminophen (PO) | Tylenol with Codeine #3, Tylenol with Codeine #4 | CS-III | Opioid and Non-Opioid Analgesic Combination | Pain | Dizziness, Drowsiness, Nausea, Vomiting, constipation, Pruritus, Respiratory Depression (Dose-Related) | Risk of opioid addiction, abuse, & misuse which can lead to overdose & death; Serious, life-threatening, or fatal respiratory depression may occur; Accidental ingestion may result in fatal overdose; Prolonged use in pregnancy may result in neonatal opioid | withdrawal syndrome; Abrupt discontinuation may result in serious opioid-induced withdrawal syndrome; concomitant use of opioids with benzodiazepines or CNS depressants (including alcohol) may result in profound sedation, respiratory depression, coma, & | death; Concomitant use or discontinuation of CYP3A4 inducers, 3A4 or 2D6 inhibitors requires careful consideration; Respiratory depression & death in children after tonsillectomy or adenoidectomy who are ultra-rapid metabolizers of codeine: Hepatotoxicity |
| Naloxone (IV, IM, SQ, Intranasal) | Narcan Nasal Spray, Zimhi | Narcan Nasal Spray: OTC | Opioid Antagonist | Opioid Overdose | Opioid Withdrawal Syndrome in Opioid-Dependent Populations, Pain | |||
| Buprenorphine & Naloxone (SL) | Suboxone | CS-III | Partial Opioid Agonist and Opioid Antagonist | Opioid Use Disorder | Opioid Withdrawal Syndrome in Opioid-Dependent Populations, Constipation, Headache, Diaphoresis | Other Notes: Potentially life-threatening respiratory depression (when combined with other CNS or respiratory depressants); | Other Notes Cont.: Addition of naloxone to buprenorphine reduces the possibility of parenteral misuse by producing opioid withdrawal symptoms when injected | |
| Ferrous Sulfate (PO) | FeroSul, SlowFe | OTC | Iron Supplement | Iron Deficiency Anemia | Nausea, Stomach Upset, Constipation (Dose-Related, Dark & Tarry Stools | Accidental overdose of iron is leading cause of fatal poisoning in children under 6 years old | ||
| Cyanocobalamin (Vitamin B12) (PO, IM, SL, Intranasal) | --- | PO, SL: OTC | Water-Soluble Vitamin | Vitamin B12 Deficiency (Manifests as Macrocytic Anemia) | No Major Side Effects | |||
| Folic Acid (PO) | --- | OTC | Water-Soluble Vitamin | Folic Acid Deficiency (Manifests as Macrocytic Anemia), Prevention of Neural Tube Defects in Pregnancy | No Major Side Effects |